Impossibility Preemption Is Possible In 510(k) Device Cases
We have alluded on a couple of occasions to the likelihood that the recent generic drug implied impossibility preemption decisions in PLIVA v. Mensing, 131 S. Ct. 2567 (2011), and Mutual...To view the full article, register now.
Already a subscriber? Click here to view full article